CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.
Electrophysiology (EP) is entering a new phase in the ASC setting. What was once limited to select cases is now expanding quickly, driven by Medicare policy updates, coding changes, and growing ...
TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the market for electrophysiology (EP) mapping and ablation ...
Is interventional electrophysiology poised for a paradigm shift? The American College of Cardiology and Heart Rhythm Society may think so. In a joint scientific statement, they offer guidance on ...
Please provide your email address to receive an email when new articles are posted on . Advanced electrophysiology fellowship training is essential for operators conducting AF ablations. Complete ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/694aa6/us_markets_for_ele) has announced the addition of the "US Markets for ...
Johnson & Johnson recently received U.S. FDA approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform, an ablation ...
Asianet Newsable on MSN
Heart health check: Warning signs that need expert care, role of EP study tests
Heart symptoms like chest pain, palpitations, and unusual fatigue should not be ignored, as early diagnosis can prevent ...
Johnson & Johnson advances cardiac ablation technology in Europe with availability of Dual Energy THERMOCOOL SMARTTOUCH SF Platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results